Pioneers in AOX biology.
Driving the development of next generation antifungal agents to improve human and crop health
AlternOx Scientific Ltd is a newly established bio-pharma company developing novel, proprietary inhibitors of the enzyme alternative oxidase (AOX) to treat a wide range of multi-drug and multi-compound resistant species of fungi that now threaten human health and food security worldwide.
The global market for new and improved fungicides is growing every day. Fungal pathogens with the potential to devastate food crops or spread through human patient populations have been developing greater resistance to antifungal treatments over the decades. The situation demands a novel approach to secure food production and protect our health.
AlternOx Scientific has developed an expanding library of AOX targeting antifungal compounds based on pioneering research by Prof. Tony Moore at the University of Sussex. This unique solution holds the key to the next generation of smarter antifungal remedies.
Publications and Press
+44 (0)1494 488 454 | a.cooper@alternox.com